tazarotene · Bausch · NDA 211882
Arazlo
Earliest generic entry, as listed
11 May 2038
Blocked by patent: US 11311482, US 12128137.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11311482 | use U-2368 | 11 May 2038 |
| US 12128137 | product, use U-2368 | 11 May 2038 |
| US 11679116 | product | 6 Jun 2036 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 211882 · 001 · RLD | lotion, topical | 0.045% | 11 May 2038 |